Formulation containing anti-inflammatory androstane derivative | Patent Number 07541350

US 07541350 B2
Application Number10918779
Publication NumberUS 20050020549 A1
Pendency4 years, 9 months, 24 days
Filled DateAug 13, 2004
Priority DateAug 3, 2001
Publication DateJan 27, 2005
Expiration DateAug 3, 2021
Inventor/ApplicantsIan Richard Buxton
Amyn Pyarali Sayani
Keith Biggadike
Kenton Lewis Reed
ExaminesBADIO, BARBARA P
Art Unit1612
Technology Center1600
Assignments
Glaxosmithkline Intellectual Property Development Limited
Current
Glaxo Group Limited
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.